Patents by Inventor John Stenos

John Stenos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11045536
    Abstract: Vaccines and methods are for immunization against Coxiella burnetii infections and Q fever. The vaccine can be for protection against a Coxiella burnetii infection, or treating or preventing at least one symptom of Q fever. The vaccine includes a delipidated C. burnetii polysaccharide derived from a cell wall lipopolysaccharide of C. burnetii. The vaccine can also be a conjugate vaccine for protection against a Coxiella burnetii infection, or treating or preventing at least one symptom of Q fever. The conjugate vaccine includes a delipidated C. burnetii polysaccharide derived from a cell wall lipopolysaccharide of C. burnetii linked to an immunogenic carrier.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: June 29, 2021
    Assignee: OZQ PTY LTD
    Inventors: Stephen Roger Graves, John Stenos, Moira Cecelia Graves, Rudolf Toman, Rodney Carbis
  • Publication number: 20200345824
    Abstract: Vaccines and methods are for immunization against Coxiella burnetii infections and Q fever. The vaccine can be for protection against a Coxiella burnetii infection, or treating or preventing at least one symptom of Q fever. The vaccine includes a delipidated C. burnetii polysaccharide derived from a cell wall lipopolysaccharide of C. burnetii. The vaccine can also be a conjugate vaccine for protection against a Coxiella burnetii infection, or treating or preventing at least one symptom of Q fever. The conjugate vaccine includes a delipidated C. burnetii polysaccharide derived from a cell wall lipopolysaccharide of C. burnetii linked to an immunogenic carrier.
    Type: Application
    Filed: November 6, 2018
    Publication date: November 5, 2020
    Inventors: Stephen Roger Graves, John Stenos, Moira Cecelia Graves, Rudolf Toman, Rodney Carbis
  • Patent number: 6806065
    Abstract: The present invention is directed to isolated nucleic acid molecules encoding Rickettsia felis outer membrane proteins (R. felis omp). Expression vectors and host cells comprising the nucleic acid molecules are also provided, as well as methods for increasing or decreasing the expression of R. felis omp in host cells. The invention further provides a method of screening a substance for the ability of the substance to modify R. felis omp function, and a method for isolating other R. felis omp molecules. DNA oligomers capable of hybridizing to the nucleic acid molecule encoding the R. felis omp are provided, which can be used to detect R. felis omp in a sample. An isolated R. felis omp is also provided. Antibodies specific for the protein, and fragments thereof, are provided, as are compositions comprising the protein and a compatible carrier. The subject invention further provides a method of preventing R. felis infections by R. felis present in a carrier host, and a method of reducing R.
    Type: Grant
    Filed: March 6, 2001
    Date of Patent: October 19, 2004
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Donald H. Bouyer, Patricia Crocquet-Valdes, John Stenos, David H. Walker
  • Publication number: 20020094552
    Abstract: The present invention is directed to isolated nucleic acid molecules encoding Rickettsia felis outer membrane proteins (R. felis omp). Expression vectors and host cells comprising the nucleic acid molecules are also provided, as well as methods for increasing or decreasing the expression of R. felis omp in host cells. The invention further provides a method of screening a substance for the ability of the substance to modify R. felis omp function, and a method for isolating other R. felis omp molecules. DNA oligomers capable of hybridizing to the nucleic acid molecule encoding the R. felis omp are provided, which can be used to detect R. felis omp in a sample. An isolated R. felis omp is also provided. Antibodies specific for the protein, and fragments thereof, are provided, as are compositions comprising the protein and a compatible carrier. The subject invention further provides a method of preventing R. felis infections by R. felis present in a carrier host, and a method of reducing R.
    Type: Application
    Filed: March 6, 2001
    Publication date: July 18, 2002
    Inventors: Donald H. Bouyer, Patricia Crocquet-Valdes, John Stenos, David H. Walker